This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Therapeutics Drugs. This report contains market size and forecasts of Fibromyalgia Therapeutics Drugs in global, including the following market information:
Global Fibromyalgia Therapeutics Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Fibromyalgia Therapeutics Drugs Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Fibromyalgia Therapeutics Drugs companies in 2022 (%)
The global Fibromyalgia Therapeutics Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Cymbalta (Duloxetine) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fibromyalgia Therapeutics Drugs include Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika and Switch Biotech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fibromyalgia Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fibromyalgia Therapeutics Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Fibromyalgia Therapeutics Drugs Market Segment Percentages, by Type, 2022 (%)
Cymbalta (Duloxetine)
Savella (Milnacipran)
Lyrica (Pregabalin)
Pancuronium
Others
Global Fibromyalgia Therapeutics Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Fibromyalgia Therapeutics Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Fibromyalgia Therapeutics Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Fibromyalgia Therapeutics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fibromyalgia Therapeutics Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Fibromyalgia Therapeutics Drugs revenues share in global market, 2022 (%)
Key companies Fibromyalgia Therapeutics Drugs sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Fibromyalgia Therapeutics Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Eli Lilly
Actavis
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Daiichi Sankyo
Forest Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Pierre Fabre Mdicament
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fibromyalgia Therapeutics Drugs, market overview.
Chapter 2: Global Fibromyalgia Therapeutics Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Fibromyalgia Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fibromyalgia Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fibromyalgia Therapeutics Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Fibromyalgia Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fibromyalgia Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fibromyalgia Therapeutics Drugs Overall Market Size
2.1 Global Fibromyalgia Therapeutics Drugs Market Size: 2022 VS 2029
2.2 Global Fibromyalgia Therapeutics Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fibromyalgia Therapeutics Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Fibromyalgia Therapeutics Drugs Players in Global Market
3.2 Top Global Fibromyalgia Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Fibromyalgia Therapeutics Drugs Revenue by Companies
3.4 Global Fibromyalgia Therapeutics Drugs Sales by Companies
3.5 Global Fibromyalgia Therapeutics Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fibromyalgia Therapeutics Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fibromyalgia Therapeutics Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fibromyalgia Therapeutics Drugs Players in Global Market
3.8.1 List of Global Tier 1 Fibromyalgia Therapeutics Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Fibromyalgia Therapeutics Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Fibromyalgia Therapeutics Drugs Market Size Markets, 2022 & 2029
4.1.2 Cymbalta (Duloxetine)
4.1.3 Savella (Milnacipran)
4.1.4 Lyrica (Pregabalin)
4.1.5 Pancuronium
4.1.6 Others
4.2 By Type - Global Fibromyalgia Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Fibromyalgia Therapeutics Drugs Revenue, 2018-2023
4.2.2 By Type - Global Fibromyalgia Therapeutics Drugs Revenue, 2024-2029
4.2.3 By Type - Global Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Fibromyalgia Therapeutics Drugs Sales & Forecasts
4.3.1 By Type - Global Fibromyalgia Therapeutics Drugs Sales, 2018-2023
4.3.2 By Type - Global Fibromyalgia Therapeutics Drugs Sales, 2024-2029
4.3.3 By Type - Global Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Fibromyalgia Therapeutics Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fibromyalgia Therapeutics Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Fibromyalgia Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Fibromyalgia Therapeutics Drugs Revenue, 2018-2023
5.2.2 By Application - Global Fibromyalgia Therapeutics Drugs Revenue, 2024-2029
5.2.3 By Application - Global Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Fibromyalgia Therapeutics Drugs Sales & Forecasts
5.3.1 By Application - Global Fibromyalgia Therapeutics Drugs Sales, 2018-2023
5.3.2 By Application - Global Fibromyalgia Therapeutics Drugs Sales, 2024-2029
5.3.3 By Application - Global Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Fibromyalgia Therapeutics Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Fibromyalgia Therapeutics Drugs Market Size, 2022 & 2029
6.2 By Region - Global Fibromyalgia Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Fibromyalgia Therapeutics Drugs Revenue, 2018-2023
6.2.2 By Region - Global Fibromyalgia Therapeutics Drugs Revenue, 2024-2029
6.2.3 By Region - Global Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Fibromyalgia Therapeutics Drugs Sales & Forecasts
6.3.1 By Region - Global Fibromyalgia Therapeutics Drugs Sales, 2018-2023
6.3.2 By Region - Global Fibromyalgia Therapeutics Drugs Sales, 2024-2029
6.3.3 By Region - Global Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Fibromyalgia Therapeutics Drugs Revenue, 2018-2029
6.4.2 By Country - North America Fibromyalgia Therapeutics Drugs Sales, 2018-2029
6.4.3 US Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.4.4 Canada Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.4.5 Mexico Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Fibromyalgia Therapeutics Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Fibromyalgia Therapeutics Drugs Sales, 2018-2029
6.5.3 Germany Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.5.4 France Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.5.5 U.K. Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.5.6 Italy Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.5.7 Russia Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.5.9 Benelux Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Fibromyalgia Therapeutics Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Fibromyalgia Therapeutics Drugs Sales, 2018-2029
6.6.3 China Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.6.4 Japan Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.6.5 South Korea Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.6.7 India Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Fibromyalgia Therapeutics Drugs Revenue, 2018-2029
6.7.2 By Country - South America Fibromyalgia Therapeutics Drugs Sales, 2018-2029
6.7.3 Brazil Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.7.4 Argentina Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Sales, 2018-2029
6.8.3 Turkey Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.8.4 Israel Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
6.8.6 UAE Fibromyalgia Therapeutics Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Fibromyalgia Therapeutics Drugs Major Product Offerings
7.1.4 Pfizer Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Fibromyalgia Therapeutics Drugs Major Product Offerings
7.2.4 Eli Lilly Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Actavis
7.3.1 Actavis Company Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Fibromyalgia Therapeutics Drugs Major Product Offerings
7.3.4 Actavis Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Actavis Key News & Latest Developments
7.4 Merck Sharp and Dohme
7.4.1 Merck Sharp and Dohme Company Summary
7.4.2 Merck Sharp and Dohme Business Overview
7.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Major Product Offerings
7.4.4 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Merck Sharp and Dohme Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Major Product Offerings
7.5.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Innovative Med Concepts
7.6.1 Innovative Med Concepts Company Summary
7.6.2 Innovative Med Concepts Business Overview
7.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Major Product Offerings
7.6.4 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Innovative Med Concepts Key News & Latest Developments
7.7 Meda
7.7.1 Meda Company Summary
7.7.2 Meda Business Overview
7.7.3 Meda Fibromyalgia Therapeutics Drugs Major Product Offerings
7.7.4 Meda Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Meda Key News & Latest Developments
7.8 Meiji Seika
7.8.1 Meiji Seika Company Summary
7.8.2 Meiji Seika Business Overview
7.8.3 Meiji Seika Fibromyalgia Therapeutics Drugs Major Product Offerings
7.8.4 Meiji Seika Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Meiji Seika Key News & Latest Developments
7.9 Switch Biotech
7.9.1 Switch Biotech Company Summary
7.9.2 Switch Biotech Business Overview
7.9.3 Switch Biotech Fibromyalgia Therapeutics Drugs Major Product Offerings
7.9.4 Switch Biotech Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Switch Biotech Key News & Latest Developments
7.10 Theravance
7.10.1 Theravance Company Summary
7.10.2 Theravance Business Overview
7.10.3 Theravance Fibromyalgia Therapeutics Drugs Major Product Offerings
7.10.4 Theravance Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Theravance Key News & Latest Developments
7.11 Zynerba Pharmaceuticals
7.11.1 Zynerba Pharmaceuticals Company Summary
7.11.2 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Business Overview
7.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Major Product Offerings
7.11.4 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Zynerba Pharmaceuticals Key News & Latest Developments
7.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
7.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Summary
7.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Business Overview
7.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Major Product Offerings
7.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Key News & Latest Developments
7.13 Daiichi Sankyo
7.13.1 Daiichi Sankyo Company Summary
7.13.2 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Business Overview
7.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Major Product Offerings
7.13.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Daiichi Sankyo Key News & Latest Developments
7.14 Forest Pharmaceuticals, Inc.
7.14.1 Forest Pharmaceuticals, Inc. Company Summary
7.14.2 Forest Pharmaceuticals, Inc. Business Overview
7.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Major Product Offerings
7.14.4 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Forest Pharmaceuticals, Inc. Key News & Latest Developments
7.15 Boehringer Ingelheim GmbH
7.15.1 Boehringer Ingelheim GmbH Company Summary
7.15.2 Boehringer Ingelheim GmbH Business Overview
7.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Major Product Offerings
7.15.4 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.16 Pierre Fabre Mdicament
7.16.1 Pierre Fabre Mdicament Company Summary
7.16.2 Pierre Fabre Mdicament Business Overview
7.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Major Product Offerings
7.16.4 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Pierre Fabre Mdicament Key News & Latest Developments
8 Global Fibromyalgia Therapeutics Drugs Production Capacity, Analysis
8.1 Global Fibromyalgia Therapeutics Drugs Production Capacity, 2018-2029
8.2 Fibromyalgia Therapeutics Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Fibromyalgia Therapeutics Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fibromyalgia Therapeutics Drugs Supply Chain Analysis
10.1 Fibromyalgia Therapeutics Drugs Industry Value Chain
10.2 Fibromyalgia Therapeutics Drugs Upstream Market
10.3 Fibromyalgia Therapeutics Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fibromyalgia Therapeutics Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Fibromyalgia Therapeutics Drugs in Global Market
Table 2. Top Fibromyalgia Therapeutics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fibromyalgia Therapeutics Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fibromyalgia Therapeutics Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Fibromyalgia Therapeutics Drugs Sales by Companies, (Kg), 2018-2023
Table 6. Global Fibromyalgia Therapeutics Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fibromyalgia Therapeutics Drugs Price (2018-2023) & (USD/g)
Table 8. Global Manufacturers Fibromyalgia Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Fibromyalgia Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibromyalgia Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Fibromyalgia Therapeutics Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Fibromyalgia Therapeutics Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Fibromyalgia Therapeutics Drugs Sales (Kg), 2018-2023
Table 15. By Type - Global Fibromyalgia Therapeutics Drugs Sales (Kg), 2024-2029
Table 16. By Application ? Global Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Fibromyalgia Therapeutics Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fibromyalgia Therapeutics Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Fibromyalgia Therapeutics Drugs Sales (Kg), 2018-2023
Table 20. By Application - Global Fibromyalgia Therapeutics Drugs Sales (Kg), 2024-2029
Table 21. By Region ? Global Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Fibromyalgia Therapeutics Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fibromyalgia Therapeutics Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Fibromyalgia Therapeutics Drugs Sales (Kg), 2018-2023
Table 25. By Region - Global Fibromyalgia Therapeutics Drugs Sales (Kg), 2024-2029
Table 26. By Country - North America Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Fibromyalgia Therapeutics Drugs Sales, (Kg), 2018-2023
Table 29. By Country - North America Fibromyalgia Therapeutics Drugs Sales, (Kg), 2024-2029
Table 30. By Country - Europe Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Fibromyalgia Therapeutics Drugs Sales, (Kg), 2018-2023
Table 33. By Country - Europe Fibromyalgia Therapeutics Drugs Sales, (Kg), 2024-2029
Table 34. By Region - Asia Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Fibromyalgia Therapeutics Drugs Sales, (Kg), 2018-2023
Table 37. By Region - Asia Fibromyalgia Therapeutics Drugs Sales, (Kg), 2024-2029
Table 38. By Country - South America Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Fibromyalgia Therapeutics Drugs Sales, (Kg), 2018-2023
Table 41. By Country - South America Fibromyalgia Therapeutics Drugs Sales, (Kg), 2024-2029
Table 42. By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Sales, (Kg), 2018-2023
Table 45. By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Sales, (Kg), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Fibromyalgia Therapeutics Drugs Product Offerings
Table 48. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Fibromyalgia Therapeutics Drugs Product Offerings
Table 52. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Actavis Company Summary
Table 55. Actavis Fibromyalgia Therapeutics Drugs Product Offerings
Table 56. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 57. Actavis Key News & Latest Developments
Table 58. Merck Sharp and Dohme Company Summary
Table 59. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Offerings
Table 60. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 61. Merck Sharp and Dohme Key News & Latest Developments
Table 62. Daiichi Sankyo Company Summary
Table 63. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Offerings
Table 64. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 65. Daiichi Sankyo Key News & Latest Developments
Table 66. Innovative Med Concepts Company Summary
Table 67. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Offerings
Table 68. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 69. Innovative Med Concepts Key News & Latest Developments
Table 70. Meda Company Summary
Table 71. Meda Fibromyalgia Therapeutics Drugs Product Offerings
Table 72. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 73. Meda Key News & Latest Developments
Table 74. Meiji Seika Company Summary
Table 75. Meiji Seika Fibromyalgia Therapeutics Drugs Product Offerings
Table 76. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 77. Meiji Seika Key News & Latest Developments
Table 78. Switch Biotech Company Summary
Table 79. Switch Biotech Fibromyalgia Therapeutics Drugs Product Offerings
Table 80. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 81. Switch Biotech Key News & Latest Developments
Table 82. Theravance Company Summary
Table 83. Theravance Fibromyalgia Therapeutics Drugs Product Offerings
Table 84. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 85. Theravance Key News & Latest Developments
Table 86. Zynerba Pharmaceuticals Company Summary
Table 87. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Offerings
Table 88. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 89. Zynerba Pharmaceuticals Key News & Latest Developments
Table 90. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Summary
Table 91. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Offerings
Table 92. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 93. Tonix Pharmaceuticals Holding Corp. (TNXP) Key News & Latest Developments
Table 94. Daiichi Sankyo Company Summary
Table 95. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Offerings
Table 96. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 97. Daiichi Sankyo Key News & Latest Developments
Table 98. Forest Pharmaceuticals, Inc. Company Summary
Table 99. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Offerings
Table 100. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 101. Forest Pharmaceuticals, Inc. Key News & Latest Developments
Table 102. Boehringer Ingelheim GmbH Company Summary
Table 103. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Offerings
Table 104. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 105. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 106. Pierre Fabre Mdicament Company Summary
Table 107. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Offerings
Table 108. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 109. Pierre Fabre Mdicament Key News & Latest Developments
Table 110. Fibromyalgia Therapeutics Drugs Production Capacity (Kg) of Key Manufacturers in Global Market, 2021-2023 (Kg)
Table 111. Global Fibromyalgia Therapeutics Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Fibromyalgia Therapeutics Drugs Production by Region, 2018-2023 (Kg)
Table 113. Global Fibromyalgia Therapeutics Drugs Production by Region, 2024-2029 (Kg)
Table 114. Fibromyalgia Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 115. Fibromyalgia Therapeutics Drugs Market Drivers in Global Market
Table 116. Fibromyalgia Therapeutics Drugs Market Restraints in Global Market
Table 117. Fibromyalgia Therapeutics Drugs Raw Materials
Table 118. Fibromyalgia Therapeutics Drugs Raw Materials Suppliers in Global Market
Table 119. Typical Fibromyalgia Therapeutics Drugs Downstream
Table 120. Fibromyalgia Therapeutics Drugs Downstream Clients in Global Market
Table 121. Fibromyalgia Therapeutics Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fibromyalgia Therapeutics Drugs Segment by Type in 2022
Figure 2. Fibromyalgia Therapeutics Drugs Segment by Application in 2022
Figure 3. Global Fibromyalgia Therapeutics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fibromyalgia Therapeutics Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fibromyalgia Therapeutics Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Fibromyalgia Therapeutics Drugs Sales in Global Market: 2018-2029 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Fibromyalgia Therapeutics Drugs Revenue in 2022
Figure 9. By Type - Global Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Fibromyalgia Therapeutics Drugs Price (USD/g), 2018-2029
Figure 13. By Application - Global Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Fibromyalgia Therapeutics Drugs Price (USD/g), 2018-2029
Figure 17. By Region - Global Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 23. US Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 28. Germany Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 37. China Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Fibromyalgia Therapeutics Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Fibromyalgia Therapeutics Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Fibromyalgia Therapeutics Drugs Production Capacity (Kg), 2018-2029
Figure 53. The Percentage of Production Fibromyalgia Therapeutics Drugs by Region, 2022 VS 2029
Figure 54. Fibromyalgia Therapeutics Drugs Industry Value Chain
Figure 55. Marketing Channels
